[Tumor marker ca. 125 in acute pelvic inflammations]. 1990

A Panazzolo, and A Fantoni, and A Chiappa, and S Ferreri, and B Amosso
Divisione di Ostetricia e Ginecologia, USSL 25, Ospedale Zonale, Rivoli.

The paper reports a case of acute pelvic inflammatory disease (PID): the symptoms, diagnostic treatment and therapy, which was carried out according to standard protocols, the operation and the postoperative period were all fully correlated with serum concentrations of the marker ca. 125. Above all, a close interdependence was observed between the clinical regression of disease and the parallel reduction of marker serum levels. The graphic curve of ca. 125 was compared during the postoperative period to the curves expressed by the levels of GB and VES values. The method of monitoring highlighted the parallelism of the three curves with a particular affinity between the ca. 125 and GB curves.

UI MeSH Term Description Entries
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000292 Pelvic Inflammatory Disease A spectrum of inflammation involving the female upper genital tract and the supporting tissues. It is usually caused by an ascending infection of organisms from the endocervix. Infection may be confined to the uterus (ENDOMETRITIS), the FALLOPIAN TUBES; (SALPINGITIS); the ovaries (OOPHORITIS), the supporting ligaments (PARAMETRITIS), or may involve several of the above uterine appendages. Such inflammation can lead to functional impairment and infertility. Adnexitis,Inflammatory Disease, Pelvic,Inflammatory Pelvic Disease,Pelvic Disease, Inflammatory,Disease, Inflammatory Pelvic,Disease, Pelvic Inflammatory,Diseases, Inflammatory Pelvic,Diseases, Pelvic Inflammatory,Inflammatory Diseases, Pelvic,Inflammatory Pelvic Diseases,Pelvic Diseases, Inflammatory,Pelvic Inflammatory Diseases
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers

Related Publications

A Panazzolo, and A Fantoni, and A Chiappa, and S Ferreri, and B Amosso
June 1995, Schweizerische medizinische Wochenschrift,
A Panazzolo, and A Fantoni, and A Chiappa, and S Ferreri, and B Amosso
November 1996, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
A Panazzolo, and A Fantoni, and A Chiappa, and S Ferreri, and B Amosso
January 2003, European journal of gynaecological oncology,
A Panazzolo, and A Fantoni, and A Chiappa, and S Ferreri, and B Amosso
April 2006, Vojnosanitetski pregled,
A Panazzolo, and A Fantoni, and A Chiappa, and S Ferreri, and B Amosso
October 1989, British journal of obstetrics and gynaecology,
A Panazzolo, and A Fantoni, and A Chiappa, and S Ferreri, and B Amosso
May 1989, British journal of obstetrics and gynaecology,
A Panazzolo, and A Fantoni, and A Chiappa, and S Ferreri, and B Amosso
January 2005, Medicina,
A Panazzolo, and A Fantoni, and A Chiappa, and S Ferreri, and B Amosso
October 2010, Revista espanola de cardiologia,
A Panazzolo, and A Fantoni, and A Chiappa, and S Ferreri, and B Amosso
July 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
A Panazzolo, and A Fantoni, and A Chiappa, and S Ferreri, and B Amosso
February 1994, Harefuah,
Copied contents to your clipboard!